Hjem › Brystkreft › Kansas › Overland Park
Kliniske studier for Brystkreft i Overland Park, KS
10 studier for Brystkreft søker deltakere på steder i og rundt Overland Park (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
RekruttererFase 1/2
- University of Kansas Hospital-Cancer Center, Fairway · 3 mi unna
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- KCCC Overland Park, Overland Park
- Overland Park Regional Medical Center, Overland Park
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruttererFase 3
- University of Kansas Cancer Center-Overland Park, Overland Park
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
RekruttererFase 2
- University of Kansas Medical Center, Fairway · 3 mi unna
Integrated Cancer Repository for Cancer Research
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Saint Luke's Cancer Instititute - South, Overland Park
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
RekruttererFase 2
- KUCC - Indian Creek, Overland Park
- KUCC - Overland Park, Overland Park
- The University of Kansas Cancer Center (KUCC), Fairway · 3 mi unna
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekruttererFase 3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Overland Park
- Ikke-småcellet lungekreft16 studier
- Akut myelogen leukemi11 studier
- Lungekreft11 studier
- Atrieflimmer8 studier
- Kolorektal kreft8 studier
- Fedme7 studier
- Pankreaskreft7 studier
- Prostatakreft7 studier
- Melanom6 studier
- Overvekt6 studier
- Eggstokkreft6 studier
- Kreft (alle typer)5 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.